October, 2005
No. 90 (10)

Articles

Combined therapy with deferiprone and desferrioxamine in thalassemia major (101 Online Views)

R Origa, P Bina, A Agus, G Crobu, E Defraia, C Dessi, G Leoni, PP Muroni, R Galanello

https://doi.org/10.3324/%25x

Comparative Studies

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities (31 Online Views)

HM van der Straaten, A van Biezen, R Brand, AV Schattenberg, RM Egeler, RM Barge, JJ Cornelissen, HC Schouten, GJ Ossenkoppele, LF Verdonck, Netherlands Stem Cell Transplant Registry "TYPHON"

https://doi.org/10.3324/%25x

A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation (158 Online Views)

S Cesaro, M Pillon, E Talenti, T Toffolutti, E Calore, G Tridello, L Strugo, R Destro, MV Gazzola, S Varotto, G Errigo, M Carli, L Zanesco, C Messina

https://doi.org/10.3324/%25x

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma (43 Online Views)

M van Agthoven, MH Kramer, P Sonneveld, KG van der Hem, PC Huijgens, PW Wijermans, HC Kluin-Nelemans, MR Schaafsma, DH Biesma, V Mattijssen, CA Uyl-de Groot, A Hagenbeek

https://doi.org/10.3324/%25x

Clinical Trial, Phase II

Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study (59 Online Views)

C Langer, E Lengfelder, J Thiele, HM Kvasnicka, HL Pahl, H Beneke, S Schauer, H Gisslinger, M Griesshammer

https://doi.org/10.3324/%25x

Clinical Trial, Phase I

Comments